Teva Pharmaceutical Industries (NYSE:TEVA) downgraded to Underweight with a $16 (22% downside risk) price target by Morgan Stanley. Downgraded to Market Perform with a $26 (26% upside) price target by Bank of Jerusalem. Shares are down 5% premarket on robust volume.
August 7th, 2017 at 8:01 am
Teva Pharmaceutical Industries (NYSE:TEVA) downgraded to Underweight with a $16 (22% downside risk) price target by Morgan Stanley. Downgraded to Market Perform with a $26 (26% upside) price target by Bank of Jerusalem. Shares are down 5% premarket on robust volume.